About
Nuvaira develops a bronchoscopic device and procedure intended to treat lung diseases such as chronic obstructive pulmonary disease (COPD) by disrupting nerve input to the lungs to improve lung function and reduce symptoms.
Explore Nuvaira's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.